Jefferies initiates coverage of Electra Therapeutics with buy rating, $32 price target
ETRA•Jefferies initiated coverage of Electra Therapeutics with a buy rating and a $32 price target.
Related News
Shattuck Labs to present SL-846 bispecific antibody data at UEG Week 2026
STTK•
Verde Resources secures ASTM EPD verification for engineered biochar used in road applications
VRDR•
Adani Enterprises and Jabil sign MoU for 50:50 data centre hardware joint venture
JBL•
Buyout barons' insurance pots are due a shakeup
APO•
RTX Raytheon wins $729 million counter-drone contracts from U.S. Army, Qatar and Jordan
RTX•